Trouver les centres d'investigation participants et le statut actuel de l’étude dans chacun d’entre eux

    Trouver les centres d'investigation participants

    A study to evaluate the efficacy, safety and pharmacokinetics of a higher dose of ocrelizumab in adults with primary progressive multiple sclerosis (PPMS)

    A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)

    • Maladie auto-immune
    • Sclérose en plaques (SEP)